Skip to main content

Table 6 Multivariate analysis for estimating factors associated with a 3-month response after intravitreal injection of ranibizumab

From: Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration

Variables P value* OR (95 % CI)
Sex (male) 0.511 1.879 (0.287–12.306)
Age (years) 0.602 1.038 (0.903–1.193)
Decreased proportion of subfoveal CT 0.042 1.362 (1.016–1.825)
Decreased proportion of mean temporal peripapillary CT 0.166 0.861 (0.696–1.064)
  1. *P value based on logistic regression analysis
  2. CT choroidal thickness